JLE

Magnesium Research

MENU

Dysmagnesemia in Covid-19 cohort patients: prevalence and associated factors Volume 33, issue 4, October-November-December 2020

Figures


  • Figure 1

  • Figure 2

Tables

Authors
1 Transversal Nutrition Unit and
2 Internal Medicine and Clinical Immunology. Nancy University Hospital, University of Lorraine, France
3 Université Clermont Auvergne, INRAE, UNH, Unité de Nutrition Humaine, Clermont-Ferrand, France
* Correspondence

Hypomagnesemia and hypermagnesemia could have serious implications and possibly lead to progress from a mild form to a severe outcome of Covid-19. Susceptibility of subjects with low magnesium status to develop and enhance this infection is possible. There is little data on the magnesium status of patients with Covid-19 with different degrees of severity. This study was conducted to evaluate prevalence of dysmagnesemia in a prospective Covid-19 cohort study according to the severity of the clinical manifestations and to identify factors associated.

Serum magnesium was measured in 300 of 549 patients admitted to the hospital due to severe Covid-19. According to the WHO guidelines, patients were classified as moderate, severe, or critical. 48% patients had a magnesemia below 0.75 mmol/L (defined as magnesium deficiency) including 13% with a marked hypomagnesemia (

 
What do you want to do ?
New mail